Related Experiment Video
Updated: Aug 19, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol
Insights
Younger men surviving acute myocardial infarction (AMI) showed reduced plasma apolipoprotein A-I (apo A-I) levels. Other cardiovascular risk factors like HDL cholesterol and sex hormones remained unchanged compared to controls.
Area of Science:
- Cardiology
- Biochemistry
- Endocrinology
Background:
- Acute myocardial infarction (AMI) survivors often have altered lipid profiles and hormonal balances.
- Understanding these changes is crucial for secondary prevention in younger patients.
Purpose of the Study:
- To investigate plasma levels of key cardiovascular biomarkers in non-diabetic males who experienced AMI before age 60.
- To compare these biomarkers between AMI survivors with different diastolic blood pressure levels and a healthy reference group.
Main Methods:
- Plasma samples from AMI survivors (n=60) and age-matched controls (n=32) were analyzed.
- Measurements included high-density lipoprotein (HDL) cholesterol, apolipoprotein A-I (apo A-I), gamma-glutamyl-transferase, testosterone, and oestradiol.
- AMI patients were subgrouped based on diastolic blood pressure (<90 mm Hg vs. ≥95 mm Hg).
Main Results:
- No significant differences were observed in HDL cholesterol, gamma-glutamyl-transferase, testosterone, or oestradiol levels between AMI groups and controls.
- Significantly reduced plasma levels of apolipoprotein A-I (apo A-I) were detected in both AMI survivor groups compared to the reference group.
Conclusions:
- Reduced apo A-I may be a specific biomarker in younger male AMI survivors, independent of other common risk factors.
- Further research is warranted to explore the clinical implications of low apo A-I in this population.
Abstract:
High density lipoprotein (HDL) cholesterol, apolipoprotein A-I (apo A-I), gamma-glutamyl-transferase, testosterone and oestradiol were determined in plasma in non-diabetic males who had survived an acute myocardial infarction (AMI) before the age of 60. They also had serum levels of cholesterol below 7.0 mmol/l 1 year after the AMI. On the basis of diastolic blood pressure they were subdivided into 2 groups with diastolic blood pressures below 90 mm Hg (n = 39), and with or above 95 mm Hg (n = 21) and then compared with an age-matched male non-diabetic reference group (n = 32). There were no significant differences in the levels of HDL cholesterol, gamma-glutamyl-transferase, and sex hormones between the AMI groups and the reference group. Reduced plasma levels of apo A-I were found in the AMI groups.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

